Covid-vaccine maker, Novavax Inc. (NVAX) reported a massive revenue jump and swung to profitability in the first quarter of 2025, supported by strategic partnerships, licensing deals, and cost controls.
Q1, 2025 Performance:
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.